Neuraxis, Inc. (NRXS) Stock Price

NRXSStock

$7.70+145.22%52W

Market Cap$96.69M

P/E—

PEG Ratio—

Div yield—

Beta1.38

NRXS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-2.66%

Price vs S&P 500 (4W)9.17%

VGM Score58.50

Book Value / Share (Quarterly)$0.54

P/TBV (Annual)15.48x

Revenue Growth (3Y)10.02%

Cash Flow / Share (Quarterly)$-0.46

Price vs S&P 500 (YTD)57.68%

Gross Margin (TTM)85.55%

Net Profit Margin (TTM)-144.44%

EPS (TTM)$-0.71

10-Day Avg Trading Volume0.20M

EPS Excl Extra (TTM)$-0.71

Revenue Growth (5Y)13.08%

EPS (Annual)$-0.86

ROI (Annual)-219.88%

Gross Margin (Annual)84.23%

Net Profit Margin (5Y Avg)-281.94%

Cash / Share (Quarterly)$0.67

Revenue Growth QoQ (YoY)115.72%

ROA (Last FY)-121.81%

Revenue Growth TTM (YoY)65.22%

EBITD / Share (TTM)$-0.70

Operating Margin (TTM)-144.51%

Cash Flow / Share (Annual)$-0.62

P/B Ratio14.36x

P/B Ratio (Quarterly)13.44x

Net Income / Employee (Annual)$-325,000

EV / Revenue (TTM)16.63x

Net Interest Coverage (TTM)-73.85x

ROA (TTM)-99.33%

EPS Incl Extra (Annual)$-0.86

Current Ratio (Annual)2.05x

Quick Ratio (Quarterly)2.83x

3-Month Avg Trading Volume0.11M

52-Week Price Return145.22%

Revenue / Employee (TTM)$221,500

Tangible BV / Share (Quarterly)$0.52

P/S Ratio (Annual)27.09x

Asset Turnover (Annual)0.56x

52-Week High$9.33

Operating Margin (5Y Avg)-228.01%

EPS Excl Extra (Annual)$-0.86

CapEx CAGR (5Y)34.32%

26-Week Price Return7.24%

Quick Ratio (Annual)1.85x

13-Week Price Return14.07%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)3.04x

Enterprise Value$88.42M

Revenue / Share Growth (5Y)4.46%

Asset Turnover (TTM)0.69x

Revenue / Employee (Annual)$148,700

Inventory Turnover (Annual)3.73x

Pretax Margin (Annual)-218.55%

Cash / Share (Annual)$0.47

3-Month Return Std Dev75.01%

Gross Margin (5Y Avg)86.06%

Net Income / Employee (TTM)$-319,900

ROE (Last FY)-229.47%

Net Interest Coverage (Annual)-56.08x

EPS Basic Excl Extra (Annual)$-0.86

Receivables Turnover (TTM)18.94x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.71

Receivables Turnover (Annual)16.21x

ROI (TTM)-164.65%

P/S Ratio (TTM)18.19x

Pretax Margin (5Y Avg)-281.94%

Revenue / Share (Annual)$0.39

Tangible BV / Share (Annual)$0.29

Price vs S&P 500 (52W)129.69%

Year-to-Date Return69.60%

5-Day Price Return14.58%

EPS Normalized (Annual)$-0.86

ROA (5Y Avg)-777.50%

Net Profit Margin (Annual)-218.55%

Month-to-Date Return4.48%

Cash Flow / Share (TTM)$-2.00

EBITD / Share (Annual)$-0.86

Operating Margin (Annual)-219.37%

LT Debt / Equity (Annual)0.00x

EPS Basic Excl Extra (TTM)$-0.71

P/TBV (Quarterly)13.98x

P/B Ratio (Annual)14.23x

Inventory Turnover (TTM)3.76x

Pretax Margin (TTM)-144.44%

Book Value / Share (Annual)$0.32

Price vs S&P 500 (13W)11.39%

Beta1.38x

Revenue / Share (TTM)$0.44

ROE (TTM)-169.07%

52-Week Low$2.21

vGradeF

gGradeA

mGradeA

vgmGradeC

NRXS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.32	-$0.19	+40.63%(+$0.13)
Q4 2025	Mar 19, 2026	-$0.21	-$0.10	+53.95%(+$0.12)
Q3 2025	Nov 10, 2025	-$0.20	-$0.24	-20.00%(-$0.04)
Q2 2025	Aug 12, 2025	-$0.19	-$0.22	-15.79%(-$0.03)

NRXS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About Neuraxis, Inc.

Neuraxis Inc is a growth-stage company developing neuromodulation therapies for chronic and debilitating conditions in children and adolescents. The company's proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology targets disorders of gut-brain interaction (DGBIs) in the pediatric population.

NRXS Insider Transactions

BuyOct 8, 2026
HENRICHS TIMOTHY ROBERT
Chief Financial Officer
Shares: 1,937Value: $13,230
BuyOct 8, 2026
CARRICO THOMAS JOESEPH
Officer
Shares: 328Value: $2,240
BuyOct 8, 2026
CARRICO BRIAN ALLEN
Chief Executive Officer
Shares: 268Value: $1,830

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

NYXHNyxoah SA Ordinary SharesSurgical & Medical Instruments
SEERSeer, Inc. Class A Common StockLab Analytical Instruments
CODACoda Octopus Group, Inc. Common stockDefense Systems & Equipment
APYXApyx Medical Corporation Common StockSurgical & Medical Instruments
PYPDPolyPid Ltd. Ordinary SharesSurgical & Medical Instruments
KEQUKewaunee Scientific CorpLab Apparatus & Furniture
LUCDLucid Diagnostics Inc. Common StockSurgical & Medical Instruments
LAKELakeland Industries IncOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.21

High$9.33